Final Thoughts on Improving Prostate Cancer Care


For High-Definition, Click

The advancement of quality care will be dependent on urology practices accumulating and analyzing outcomes and cost data, believes Sanford J. Siegel, MD. Furthermore, large integrated practices must embrace the use of new technology, suggests Richard Harris, MD. Practices must also recognize the importance of partnering and integrating other services to provide all of the tests necessary to improve care, Gary M. Kirsh, MD adds.

Neal D. Shore, MD, emphasizes the need to constantly conduct new research and look for ways to improve care. Shore describes these sentiments in three short statements: “Inertia is the enemy. Leadership is essential. Innovation is mandatory.”

View the video, to hear more from the panelists.

Related Videos
Petros Grivas, MD, PhD, professor, Clinical Research Division, Fred Hutchinson Cancer Center; professor, Division of Hematology and Oncology, University of Washington (UW) School of Medicine; clinical director, Genitourinary Cancers Program, UW Medicine
Phillip J. Koo, MD
A panel of 5 experts on renal cell carcinoma
Chandler H. Park, MD, an expert on renal cell carcinoma
Phillip J. Koo, MD
Benjamin Garmezy, MD
Samer A. Srour, MB ChB, MS
Wenxin (Vincent) Xu, MD,
A panel of 5 experts on renal cell carcinoma
A panel of 5 experts on renal cell carcinoma